Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

NCT01571284 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

781

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer Metastatic

Interventions

DRUG: AFLIBERCEPT AVE0005
DRUG: FOLFIRI

Sponsor

Sanofi

Collaborators

[object Object]